GEMMABio Appoints Dr. May Orfali as Chief Medical Officer | PR Newswire [Video]

Experienced medical executive brings expansive knowledge in clinical development and medical affairs

, /PRNewswire/ — GEMMA Biotherapeutics (“GEMMABio”) – a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson – today announced that it has named May Orfali, MD, MBA, as Chief Medical Officer.

Dr. Orfali brings nearly three decades of experience in clinical development and medical affairs. She has expertise in multiple therapeutic areas, including oncology, infectious diseases, and rare and orphan diseases. She has led clinical development, clinical operations, biostatistics, medical affairs, patient affairs, and regulatory and strategy execution for several successful companies.

“We are thrilled to welcome May to our team, whose multi-faceted background in pharmaceuticals and international health coupled with her proven leadership in advancing clinical programs will be hugely impactful to our growing company,” said Dr. Wilson, President and CEO of GEMMABio. “Having led programs and teams focused on a variety of diseases as well as overseeing innovative platforms involving data, artificial intelligence (AI) and biological …